Some research into GLP-1 receptor agonists has suggested potential neuroprotective effects and possible benefits for certain neuropsychiatric conditions, though this research is in early stages and not specific to bipolar disorder
We hope to gather more detailed data in future, monitoring how trends change over time
Toft G, Thulstrup AM, Jonsson BA, Pedersen HS, Ludwicki JK, Zvezday V, Bonde JP: Fetal loss and maternal serum levels of 2,2',4,4',5,5'-hexachlorbiphenyl (CB-153) and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p, p'-DDE) exposure: a cohort study in Greenland and two European populations
Staying Informed Keep up with new developments by following reputable medical sources and discussing updates with your healthcare provider
Semaglutide# Semaglutide is a 31-amino acid GLP-1 receptor agonist with a C18 fatty diacid enabling albumin binding and a 7-day half-life
Both list Mounjaro as a tier 2 drug with quantity limits and prior authorization required